Visceral Larva Migrans (Toxocara)

Visceral larva migrans (VLM) is the most common clinical form of toxocariasis, occurring predominantly in young children aged 1–7 after ingestion of large numbers of Toxocara eggs from contaminated soil or sandboxes. Larvae hatch, penetrate the gut wall, and migrate through the liver, lungs, and other organs, triggering intense eosinophilic granulomatous inflammation. The hallmark is profound persistent eosinophilia, sometimes reaching 30–80% of the white blood cell differential.

Table of Contents

  1. Pathogenesis and Mechanism
  2. Who Gets VLM
  3. Eosinophilia — The Hallmark Lab Finding
  4. Hepatic Involvement
  5. Pulmonary Involvement
  6. Systemic Symptoms
  7. Covert Toxocariasis — The Mild Adult Form
  8. Neurotoxocariasis and Cardiac Involvement
  9. Key Research Papers
  10. Connections
  11. Featured Videos

1. Pathogenesis and Mechanism

After a child ingests embryonated Toxocara eggs — typically from contaminated sandbox sand, garden soil, or dirty hands — the eggs hatch in the small intestine, releasing second-stage larvae (L2). These larvae, roughly 400 µm long, penetrate the intestinal mucosa and enter the portal circulation.

From the portal vein, larvae enter the liver sinusoids and lodge in hepatic tissue, where they begin their migratory path through parenchyma. Many larvae are trapped in the liver; others escape into the hepatic veins and reach the right heart, then the pulmonary circulation, where some are trapped in capillaries while others traverse the lung and spread systemically via the arterial circulation to virtually any organ — brain, eye, heart, muscles, kidneys.

As larvae migrate, they leave behind a trail of eosinophilic granulomas: aggregations of eosinophils, macrophages, lymphocytes, and multinucleated giant cells surrounding the dying or encapsulated larva. These granulomas are the histological hallmark of VLM. The immune response also produces massive peripheral eosinophilia, elevated IgE, and hypergammaglobulinemia as hallmarks of the systemic response.

Back to Table of Contents

2. Who Gets VLM

VLM requires ingestion of a substantial egg burden — the disease is generally associated with heavy exposure. The typical patient is:

Boys may be more commonly affected than girls due to higher likelihood of outdoor soil play and pica behaviors. African American children in the southeastern US have the highest documented seroprevalence, reflecting environmental and socioeconomic exposure gradients.

Back to Table of Contents

3. Eosinophilia — The Hallmark Lab Finding

The single most important laboratory clue to VLM is persistent eosinophilia. In VLM:

Eosinophilia is a reactive response to larval excretory-secretory products and is driven by IL-5 produced by Th2-polarized T cells. The degree of eosinophilia roughly correlates with worm burden. Crucially, eosinophilia is characteristically absent or mild in ocular larva migrans (OLM), which helps distinguish the two syndromes clinically.

Back to Table of Contents

4. Hepatic Involvement

The liver is the primary target organ in VLM because larvae from the portal circulation first traverse the liver before escaping systemically. Hepatic involvement produces:

Liver histology (when biopsy is performed) shows eosinophilic granulomas with central necrosis and larval remnants. In practice, biopsy is rarely necessary — clinical presentation plus serology and imaging is usually sufficient for diagnosis. Hepatic granulomas typically resolve completely over months as the inflammatory response subsides after larval death.

Back to Table of Contents

5. Pulmonary Involvement

Pulmonary VLM occurs when larvae traverse the liver and enter the pulmonary circulation. Symptoms and findings include:

The pulmonary phase of VLM resembles Löffler syndrome, a pattern of transient pulmonary infiltrates with eosinophilia that can also be caused by other migrating helminths (Ascaris, Strongyloides, hookworm). The history of animal exposure and serology distinguish toxocariasis. Pulmonary VLM responds well to albendazole and typically resolves without permanent lung damage.

Back to Table of Contents

6. Systemic Symptoms

Beyond the liver and lungs, VLM produces constitutional and systemic manifestations:

The combination of fever, hepatomegaly, hypereosinophilia, and elevated IgE in a young child with pet or soil exposure is highly characteristic of VLM. The differential diagnosis includes other causes of hypereosinophilia with organ involvement: Löffler syndrome from other helminths, hypereosinophilic syndrome, drug reactions, and eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss).

Back to Table of Contents

7. Covert Toxocariasis — The Mild Adult Form

Covert toxocariasis is a subclinical or mildly symptomatic form seen in older children and adults with lower-level exposure. It does not meet the classic criteria for VLM but produces recognizable features:

The concept of covert toxocariasis is important because it may explain a proportion of chronic unexplained eosinophilia or atopic disease in adults with pet or soil exposure. Treatment with albendazole is generally recommended when eosinophilia exceeds 1,000/µL and symptoms are present, even without full VLM syndrome.

Back to Table of Contents

8. Neurotoxocariasis and Cardiac Involvement

Rare but serious manifestations of VLM occur when larvae reach critical organs:

Neurotoxocariasis presents as eosinophilic meningitis (headache, CSF pleocytosis with eosinophils), encephalitis, seizures, or behavioral changes. Brain MRI shows white matter lesions and migratory tracts. CSF serology for Toxocara antibodies supports diagnosis. Treatment requires extended albendazole (21 days) plus corticosteroids.

Cardiac toxocariasis produces eosinophilic myocarditis with arrhythmias, cardiomegaly, and in severe cases, heart failure. Troponin elevation and ECG changes may be present. Cardiac MRI with late gadolinium enhancement demonstrates myocardial involvement. Both neurotoxocariasis and cardiac involvement are markers of very heavy larval burden and require aggressive treatment. Fatal cases, while rare, have been reported with massive VLM and cardiac or neurological compromise.

Back to Table of Contents

Key Research Papers

  1. Rubinsky-Elefant G, et al. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression. Ann Trop Med Parasitol. 2010;104:3–23. PMID 22342680
  2. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265–272. PMID 18947176
  3. Won KY, et al. National seroprevalence and risk factors for zoonotic Toxocara spp. infection. Am J Trop Med Hyg. 2008;79:552–557. PMID 20459450
  4. Fillaux J, Magnaval JF. Laboratory diagnosis of human toxocariasis. Vet Parasitol. 2013;193:327–336. PMID 27476813
  5. Beaver PC, et al. Chronic eosinophilia due to visceral larva migrans. Pediatrics. 1952;9:7–19. PMID 26026023
  6. Magnaval JF, et al. Highlights of human toxocariasis. Korean J Parasitol. 2001;39:1–11. PMID 24612786
  7. Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol. 2001;75:299–305. PMID 21990370
  8. Woodhall D, et al. Neglected parasitic infections in the US: toxocariasis. Am J Trop Med Hyg. 2014;90:810–813. PMID 28636555
  9. Iddawela DR, et al. Seroprevalence of toxocariasis. Korean J Parasitol. 2003;41:109–113. PMID 23079626
  10. Finsterer J, Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo. 2007;49:279–287. PMID 24528876

PubMed Searches

  1. VLM eosinophilia
  2. Toxocara hepatic granuloma
  3. Toxocara pulmonary Loeffler
  4. Neurotoxocariasis meningitis
  5. Covert toxocariasis asthma IgE
  6. Toxocara myocarditis cardiac

Back to Table of Contents

Back to Table of Contents

Connections

Back to Table of Contents